Firefly Neuroscience, Inc.AIFFNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
12.50%
↓ 81% below average
Average (9q)
64.53%
Historical baseline
Range
High:896.55%
Low:-100.00%
Volatility
1544.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 12.50% |
| Q2 2025 | 7.69% |
| Q1 2025 | -28.60% |
| Q4 2024 | -50.23% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | 896.55% |
| Q4 2023 | -92.60% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |